Drug Database
Back to search

Netherlands· NL-1dc0dfc5f3ac

Urokinase Syner-Medica 25.000 IE, poeder voor oplossing voor injectie/infusie

A urokinase product containing urokinase, registered in Netherlands by Syner-Medica B.V.. The same ATC class is registered in 6 of our 19 countries.

ATC B01AD04

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedUrokinase Syner-Medica 25.000 IE, poe…ATCB01AD04REGISTER NO.NL-1dc0dfc5f3acPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about urokinaseAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Urokinase is registered in 6 of 19 countries.

Countries holding a registration under ATC B01AD04 (urokinase), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 4 of them publish a price we can compare per daily dose
Search urokinase products by name

Urokinase · ATC B01AD04

6 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Japan
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
UROKINASE
Manufacturer
Syner-Medica B.V.
Country
Netherlands (NL)
ATC code
B01AD04
ATC class
Urokinase
Defined daily dose
3 MIO, E
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    122409

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

130 interactions on record for urokinase.

Graded by severity as the source publishes them — 46 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check urokinase against other medicinesHow interaction checks work

Urokinase · interactions on record

130 records

  • 46 severe
  • 84 moderate

Most severe, free to view

  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Urokinase in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All urokinase products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Austria · Urokinase Medac
  • Belgium · Actosolv, Urokinase Syner-Medica
  • Germany · Rheotromb, Syner-Kinase
  • Spain · Urokinase Teofarma, Uroquinasa Syner Medica
  • France · Actosolv, Therasolv
  • United Kingdom (Northern Ireland) · Syner-Kinase
  • Italy · Urochinasi Eg, Urokinasi Pfizer
  • Luxembourg · Actosolv
  • Poland · Urokinase Medac

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bcdae397-e17e-4707-a5ee-ad73d39ba323
GET /v1/drugs/bcdae397-e17e-4707-a5ee-ad73d39ba323?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder voor oplossing voor injectie of infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h122409_smpc.pdf",
  "strength": null,
  "atc_label": "Urokinase",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg122409",
  "excipients": [
    "DINATRIUMEDETAAT 2-WATER",
    "DINATRIUMWATERSTOFFOSFAAT 12-WATER (E 339)",
    "MANNITOL (D-) (E 421)",
    "NATRIUMHYDROXIDE (E 524)"
  ],
  "substances": [
    "UROKINASE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h122409.pdf",
  "authorised_at": "2019/11/14",
  "procedure_number": "NL/H/4884/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "122409",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about urokinase.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console